Outset Medical Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.4% | 74.7% | 70.8% | 64.3% | 65.7% | 63.5% | 62.8% | 62.2% | 60.6% | 57.6% | 56.6% | 58.0% | 58.2% | |
| 23.6% | 25.3% | 29.2% | 35.7% | 34.3% | 36.5% | 37.2% | 37.8% | 39.4% | 42.4% | 43.4% | 42.0% | 41.8% | |
| 52.9% | 41.1% | 44.9% | 35.5% | 28.4% | 26.8% | 18.5% | 16.8% | 18.3% | 17.5% | 20.2% | 17.2% | 18.2% | |
| 38.9% | 33.9% | 40.6% | 46.3% | 35.2% | 31.4% | 27.9% | 29.2% | 28.8% | 41.3% | 36.3% | 35.9% | 35.5% | |
| 173.3% | 147.7% | 160.2% | 148.0% | 117.4% | 110.7% | 92.3% | 91.4% | 93.1% | 103.4% | 104.1% | 91.5% | 97.8% | |
| -149.7% | -122.4% | -131.0% | -112.3% | -83.2% | -74.2% | -55.1% | -53.7% | -53.7% | -61.1% | -60.7% | -49.6% | -56.1% | |
| 10.6% | 11.2% | 21.2% | 21.9% | 21.2% | 19.8% | 12.0% | 11.1% | 11.8% | 11.9% | 12.1% | 10.9% | 11.7% | |
| -151.8% | -126.2% | -141.2% | -125.2% | -96.8% | -87.0% | -86.3% | -58.7% | -59.2% | -67.2% | -67.3% | -56.2% | -62.3% | |
| 0.3% | 0.4% | 0.6% | 0.6% | 0.6% | 0.0% | 0.4% | 0.3% | 1.4% | 0.3% | 0.8% | 0.7% | 0.8% | |
| -152.1% | -126.5% | -141.8% | -125.8% | -97.5% | -87.0% | -86.7% | -59.0% | -60.6% | -67.5% | -68.1% | -56.8% | -63.1% | |
| -135.4% | -110.2% | -114.9% | -97.9% | -68.2% | -62.5% | -50.8% | -43.9% | -46.3% | -52.2% | -52.4% | -40.8% | -47.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.